Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
-
WiSe 2023
- Kurs: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 1
- Wahlfach: Klinische Nuklearmedizin
- Kurs: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 2
- Moderne metabolische / funktionelle Schnittbildgebung - Standards in der klinischen Versorgung
- Anleitung zu selbständigen wissenschaftlichen Arbeiten in der Nuklearmedizin
- Multimodale Bildgebung (PET/CT, PET/MRT, SPECT/CT)
- Systematische Befundung in der Nuklearmedizin
- Kurs: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 3
- POL - Nuklearmedizin
- PJ - Seminar
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Comparative analysis of pulmonary function decline in patients undergoing bronchoscopic lung volume reduction with endobronchial valves versus conservative treatment in emphysema management : A longitudinal coarsened exact matched analysisIn: Chronic Respiratory Disease, Jg. 22, 2025, in pressDOI, Online Volltext (Open Access)
-
Detection and quantification of small and low-uptake lesions for differentiated thyroid carcinoma using non-time-of-flight iodine-124 PET/MRIIn: Medical Physics, Jg. 52, 2025, Nr. 2, S. 837 – 846DOI (Open Access)
-
Evaluation of Surgical Margins with Intraoperative PSMA PET/CT and their Prognostic Value in Radical ProstatectomyIn: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 3, S. 352 – 358
-
External phantom-based validation of a deep-learning network trained for upscaling of digital low count PET dataIn: EJNMMI Physics, Jg. 12, 2025, Nr. 1, 38DOI (Open Access)
-
Head-to-head comparison of ⁶⁸ Ga-FAPI-46 PET/CT, ¹⁸F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumorsIn: Annals of Nuclear Medicine, Jg. 39, 2025, Nr. 3, S. 255 – 265
-
Impact of functionality and grading on survival in pancreatic neuroendocrine tumor patients receiving peptide receptor radionuclide therapyIn: Frontiers in Endocrinology, Jg. 16, 2025, 1526470DOI, Online Volltext (Open Access)
-
Quantitative evaluation of ¹²³I-MIBG imaging in patients with myocarditis : Impairment of cardiac neuronal function revisitedIn: Annals of Nuclear Medicine, 2025, in pressDOI (Open Access)
-
Staging of prostate Cancer with ultra-fast PSMA-PET scans enhanced by AIIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 52, 2025, Nr. 5, S. 1658 – 1670DOI (Open Access)
-
Tumor Dose–Response Relationship of [¹³¹I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [¹²⁴I]MIBG PETIn: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 4, S. 641 – 647
-
[⁶⁸Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation : A single-centre, single-arm, interventional, phase 2 trialIn: The Lancet Oncology, Jg. 26, 2025, Nr. 9, S. 1204 – 1214DOI (Open Access)
-
Biodistribution and radiation dosimetry of ¹²⁴I-mIBG in adult patients with neural crest tumours and extrapolation to paediatric modelsIn: EJNMMI Physics, Jg. 11, 2024, Nr. 1, 3DOI, Online Volltext (Open Access)
-
Body composition impacts outcome of bronchoscopic lung volume reduction in patients with severe emphysema : A fully automated CT-based analysisIn: Scientific Reports, Jg. 14, 2024, Nr. 1, 8718DOI, Online Volltext (Open Access)
-
Correction to : Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: “A SYMPHONY OF SCIENCE”In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 51, 2024, Nr. 7, S. 2159 – 2159DOI (Open Access)
-
FAPI PET Imaging Supports Clinical Decision Making in Academic Cardiology Practice : A Pictorial Imaging VignetteIn: JACC Cardiovascular Imaging, Jg. 17, 2024, Nr. 7, S. 811 – 823DOI (Open Access)
-
Future Perspectives of Artificial Intelligence in Bone Marrow Dosimetry and Individualized Radioligand TherapyIn: Seminars in Nuclear Medicine, Jg. 54, 2024, Nr. 4, S. 460 – 469DOI (Open Access)
-
Imaging of Cardiac Fibrosis : An Update, From the AJR Special Series on Imaging of FibrosisIn: American Journal of Roentgenology (AJR online), Jg. 222, 2024, Nr. 6, e2329870
-
Imaging of Cardiac Fibrosis : How Far Have We Moved From Extracellular to Cellular?In: Seminars in Nuclear Medicine, 2024, in pressDOI (Open Access)
-
PET quantification performance of the oversize-volume-of-interest approach in the context of tumour dosimetry in radionuclide therapy planningIn: Physics in Medicine and Biology, Jg. 69, 2024, Nr. 16, 165007DOI (Open Access)
-
PSMA-PET follow-up to assess response in patients not receiving PSMA therapy : Is there value beyond localization of disease?In: Theranostics, Jg. 14, 2024, Nr. 9, S. 3623 – 3633DOI, Online Volltext (Open Access)
-
Safety and Efficacy of Para-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine TumorsIn: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 6, S. 931 – 937
-
Theranostics with somatostatin receptor antagonists in SCLC : Correlation of 68Ga-SSO120 PET with immunohistochemistry and survivalIn: Theranostics, Jg. 14, 2024, Nr. 14, S. 5400 – 5412DOI, Online Volltext (Open Access)
-
Understanding homologous recombination repair deficiency in biliary tract cancers : clinical implications and correlation with platinum sensitivityIn: ESMO Open, Jg. 9, 2024, Nr. 8, 103630DOI (Open Access)
-
18F-PSMA Cerenkov Luminescence and Flexible Autoradiography Imaging in a Prostate Cancer Mouse Model and First Results of a Radical Prostatectomy Feasibility Study in MenIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 4, S. 598 – 604DOI (Open Access)
-
68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients : A Single-Center Retrospective StudyIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 10, S. 1540 – 1549DOI (Open Access)
-
Evaluation of thresholding methods for the quantification of [⁶⁸Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapyIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 50, 2023, Nr. 7, S. 2196 – 2209DOI (Open Access)
-
Is There a Role of Artificial Intelligence in Preclinical Imaging?In: Seminars in Nuclear Medicine, Jg. 53, 2023, Nr. 5, S. 687 – 693
-
Lesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic FAPI Radionuclide TherapyIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 2, S. 329 – 336DOI (Open Access)
-
Methodological evaluation of original articles on radiomics and machine learning for outcome prediction based on positron emission tomography (PET)In: Nuklearmedizin = Nuclear Medicine, Jg. 62, 2023, Nr. 6, S. 361 – 369DOI (Open Access)
-
Molecular Imaging Biomarkers in Cardiooncology : A View on Established Technologies and Future PerspectivesIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. Suppl. 2, S. 29S – 38SDOI (Open Access)
-
PSMA-Directed Imaging and Therapy of Salivary Gland Tumors : A Single-Center Retrospective StudyIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 3, S. 372 – 378DOI (Open Access)
-
Prognostic Implications of PET-Derived Tumor Volume and Uptake in Patients with Neuroendocrine TumorsIn: Cancers, Jg. 15, 2023, Nr. 14, 3581DOI (Open Access)
-
Quantification performance of silicon photomultiplier-based PET for small ¹⁸F-, ⁶⁸Ga- and ¹²⁴I-avid lesions in the context of radionuclide therapy planningIn: Physica Medica: European Journal of Medical Physics, Jg. 114, 2023, 103149DOI (Open Access)
-
Quantitative ⁹⁹mTc-DPD-SPECT/CT assessment of cardiac amyloidosisIn: Journal of Nuclear Cardiology, Jg. 30, 2023, Nr. 1, S. 101 – 111DOI (Open Access)
-
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision : A phantom studyIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 67, 2023, Nr. 1, S. 57 – 68
-
Regression of Myocardial ⁹⁹mTc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin AmyloidosisIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 7, S. 1083 – 1086DOI (Open Access)
-
Artificial intelligence guided enhancement of digital PET : Scans as fast as CT?In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, Nr. 13, S. 4503 – 4515DOI (Open Access)
-
Clinical Use of PET/MR in Oncology : An UpdateIn: Seminars in Nuclear Medicine, Jg. 52, 2022, Nr. 3, S. 356 – 364
-
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI) : A Single-Center Prospective Two-Arm StudyIn: Clinical Cancer Research, Jg. 28, 2022, Nr. 19, S. 4194 – 4202DOI (Open Access)
-
First experiences with dynamic renal [⁶⁸Ga]Ga-DOTA PET/CT : A comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rateIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, Nr. 10, S. 3373 – 3386DOI (Open Access)
-
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification : A post-hoc analysis of the PETAL trialIn: Leukemia, Jg. 36, 2022, Nr. 12, S. 2845 – 2852DOI (Open Access)
-
Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital systemIn: BMC Cancer, Jg. 22, 2022, Nr. 1, 899DOI, Online Volltext (Open Access)
-
Pitfalls and Common Findings in ⁶⁸Ga-FAPI PET : A Pictorial AnalysisIn: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 6, S. 890 – 896DOI (Open Access)
-
Repeatability of ⁶⁸Ga-PSMA-HBED-CC PET/CT-Derived Total Molecular Tumor VolumeIn: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 5, S. 746 – 753DOI (Open Access)
-
Response to letter to the editorIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, Nr. 10, S. 3336 – 3339DOI (Open Access)
-
Shining Damaged Hearts : Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear CardiologyIn: International Journal of Molecular Sciences (IJMS), Jg. 23, 2022, Nr. 7, 3802DOI, Online Volltext (Open Access)
-
The Future Role of PET Imaging in Metastatic Breast CancerIn: Oncology Research and Treatment, Jg. 45, 2022, Nr. 1-2, S. 18 – 25
-
Artificial Intelligence and Machine Learning in Nuclear Medicine : Future PerspectivesIn: Seminars in Nuclear Medicine, Jg. 51, 2021, Nr. 2, S. 170 – 177
-
Atypical bilateral ventilation/perfusion mismatches in an asymptomatic patient suffering from metastatic thyroid cancerIn: European Journal of Hybrid Imaging: EJNMMI Multimodality Journal, Jg. 5, 2021, Nr. 1, 25DOI, Online Volltext (Open Access)
-
Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancerIn: EJNMMI Physics, Jg. 8, 2021, Nr. 1, 14DOI, Online Volltext (Open Access)
-
Evaluation of [⁶⁸Ga]Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate cancer patients using the digital biograph visionIn: EJNMMI Research, Jg. 11, 2021, Nr. 1, S. 21DOI, Online Volltext (Open Access)
-
Evaluation of ¹⁸F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph visionIn: BMC Cancer, Jg. 21, 2021, Nr. 1, 62DOI, Online Volltext (Open Access)
-
Just another “Clever Hans”? : Neural networks and FDG PET-CT to predict the outcome of patients with breast cancerIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, Nr. 10, S. 3141 – 3150DOI (Open Access)
-
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTCIn: Cancers, Jg. 13, 2021, Nr. 7, S. 1728DOI, Online Volltext (Open Access)
-
Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype : A case series with literature reviewIn: Molecular Genetics & Genomic Medicine, Jg. 9, 2021, Nr. 12, e1581DOI, Online Volltext (Open Access)
-
Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124In: Scientific Reports, Jg. 11, 2021, Nr. 1, 17477DOI, Online Volltext (Open Access)
-
Total tumor volume reduction and low PSMA expression in patients receiving Lu-PSMA therapyIn: Theranostics, Jg. 11, 2021, Nr. 17, S. 8143 – 8151DOI (Open Access)
-
Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria : “A SYMPHONY OF SCIENCE”
36th EANM Annual Congress 2023 - "A symphony of science", 9. - 13. September 2023,Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 51, 2024, Nr. 7, S. 1800 – 1808DOI (Open Access) -
I see, therefore I am? : The value of artificial intelligence in nuclear imaging-based identification of cardiac amyloidosisIn: Journal of Nuclear Cardiology. New York; St. Louis, Mo.; Orlando, Fla.: Springer, Jg. 33, 2024, 101773
-
To quantify or not to quantify, that is the question : Semi-quantitative vs. visual analysis of Rb-82 myocardial perfusion imaging PETIn: Journal of Nuclear Cardiology. New York; St. Louis, Mo.; Orlando, Fla.: Springer, Jg. 29, 2022, Nr. 6, S. 3163 – 3165DOI (Open Access)
-
Clinical value of [68Ga]Ga-FAPI-46 PET in Comparison to [18F]FDG PET in Triple-negative Breast Cancer and Possible Theranostic ApplicationsIn: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 66, 2025, Nr. Supplement 1, 251520Online Volltext (Open Access)
-
Investigation of Cardiac Amyloid Deposits as a Cause of Cardiac Dysfunction in Persons with Alzheimer's Disease : The Prospective CACAO-PET StudyIn: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 66, 2025, Nr. Supplement 1, 252027Online Volltext (Open Access)
-
Homologous recombination repair (HRR) deficiency in biliary tract cancers : Clinical implications in subsequent therapy lines and correlation with platinum sensitivity
ESMO Gastrointestinal Cancers Congress 2024, 26-29 June 2024, Munich, Germany,In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Supplement 1, S. S127 -
68Ga-NeoB PET for Glioma and Breast Cancer : First Results from a Prospective Observational Trial
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S265 -
68Ga-SSO-120 versus 18F-FDG PET in the Initial Staging of Small-Cell Lung Cancer PatientsIn: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. Suppl. 1, Annual Congress of the European Association of Nuclear Medicine September 9–13, 2023 Vienna, Austria, S. 488 – S489
-
68Ga-Satoreotide PET for Staging of Small-Cell Lung Cancer PatientsIn: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 64, 2023, Nr. Suppl. 1, P165
-
Added diagnostic sensitivity of MTV and TLG in the assessment of left adrenal gland metastasis in lung cancer with [18F]FDG PET/CT
Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S485 -
Occurence of hematotoxic side effects during 90Y-FAPI-46 radioligand therapy (RLT) in patients with advanced metastatic tumor diseases
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S671DOI (Open Access) -
PET Quantification Performance of the Oversize-Volume-of-Interest Approach in the Context of Tumour Dosimetry in Radionuclide Therapy Planning
Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S363 -
Performance Evaluation of 18F-PSMA and 68Ga-PSMA in a Novel MicroPET/CT System Dedicated to Radioguided Surgery
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023, Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S131 -
Prognostic value of the post-treatment 177Lu-DOTATOC scintigraphy in NET patients undergoing PRRT
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023, Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S134 -
Screening for occult transthyretin amyloidosis in patients with degenerative aortic stenosis and amyloid red-flagsIn: European Journal of Heart Failure. Oxford: Wiley, Jg. 25, 2023, Nr. Suppl. 2, S. 359 – 359
-
PSMA-directed imaging and therapy of salivary gland tumors : a single-center retrospective study
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S229DOI (Open Access) -
Radiation Exposure of I-124-MIBG Imaging in Adult Patients with Neuroendocrine Tumours
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S36 – S37DOI (Open Access) -
Dynamic Ga-68-DOTA PET/CT and Compartmental Modelling to Non-invasively Estimate the Glomerular Filtration RateIn: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 62, 2021, Nr. Suppl. 1, 88
-
Evaluation of Dynamic Renal Ga-68-DOTA PET/CT to Monitor the Urinary Efflux and to Estimate the Glomerular Filtration Rate Using a Compartmental Kinetic Modelling ApproachIn: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. 340
-
Comparison of Lesion Detectability and Image Quality among Digital and Analog PET Systems for Recurrence in Thyroid Cancer Patients Using I-124
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S429DOI (Open Access) -
Digital high sensitivity I-124 PET/CT improves the detectability of thyroid cancer metastases
Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, July, 11-14, 2020, Virtual,In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. Suppl. 1, 255Online Volltext (Open Access) -
Evaluation of 68Ga-PSMA PET/CT Images Acquired with a Reduced Scan Time Duration in Prostate Cancer Patients using a Digital PET/CT Scanner
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S27DOI (Open Access) -
A paradigm shift: Dosimetry approaches in theranostic nuclear medicineIn: XVII Mexican Symposium on Medical Physics 2022 / 17th Mexican Symposium on Medical Physics ; 7 - 9 September 2022, Veracruz, Mexico / Morales Bárcenas, José Héctor; Ávila Aguirre, Olga Leticia; Ruíz-Trejo, César Gustavo; Massillon J-L, Guerda; Torres-García, Eugenio; Brandan, María-Ester; García-Pelagio, Karla Paola (Hrsg.). Melville; New York, NY: American Institute of Physics, 2023, 020003
-
Mirror U-Net : Marrying Multimodal Fission with Multi-task Learning for Semantic Segmentation in Medical ImagingIn: 2023 IEEE/CVF International Conference on Computer Vision Workshops: Proceedings / ICCVW 2023, 2-6 October 2023, Paris, France,. Piscataway: Institute of Electrical and Electronics Engineers Inc., 2023, S. 2275 – 2285DOI, Online Volltext (Open Access)
-
Fortschrittliche Biomarker der molekularen Bildgebung fürprädiktive und prognostische klinische AnwendungenDuisburg ; Essen, 2024
-
Characteristics and outcomes of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with lutetium-177–PSMA-617 (PSMA-RLT) in a real-world setting
2024 ASCO Genitourinary Cancers Symposium, January 25 - 27, 2024, San Francisco, CA, USA,In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. 4, Supplement, 143 -
Lesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic FAPI Radionuclide Therapy
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S636DOI (Open Access) -
Emission time optimisation for [68Ga]Ga-PSMA-11 with a SiPM PET/CT based on phantom measurements
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S256DOI (Open Access)